{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:38:55Z","timestamp":1790501935012,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573355"],"award-info":[{"award-number":["81573355"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Life Sciences at Tsinghua and Peking Universities"},{"DOI":"10.13039\/501100010871","name":"Recruitment Program of Global Experts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejps.2018.07.007","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T20:45:45Z","timestamp":1531255545000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A high-sensitivity HPLC-ELSD method for HPMC-AS quantification and its application in elucidating the release mechanism of HPMC-AS based amorphous solid dispersions"],"prefix":"10.1016","volume":"122","author":[{"given":"Shan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-6997","authenticated-orcid":false,"given":"Feng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.07.007_bb0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11095-009-0021-1","article-title":"Understanding the behavior of amorphous pharmaceutical systems during dissolution","volume":"27","author":"Alonzo","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.07.007_bb0010","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/jps.22579","article-title":"Dissolution and precipitation behavior of amorphous solid dispersions","volume":"100","author":"Alonzo","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"1-2","key":"10.1016\/j.ejps.2018.07.007_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.02.005","article-title":"Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion","volume":"540","author":"Bhardwaj","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0020","doi-asserted-by":"crossref","DOI":"10.1021\/mp5006245","article-title":"Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0025","doi-asserted-by":"crossref","DOI":"10.1021\/mp500660m","article-title":"Drug\u2013polymer\u2013water interaction and its implication for the dissolution performance of amorphous solid dispersions","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0030","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1021\/acs.molpharmaceut.6b00391","article-title":"Sodium lauryl sulfate competitively interacts with HPMC-AS and consequently reduces oral bioavailability of posaconazole\/HPMC-AS amorphous solid dispersion","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0035","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s11095-016-1969-2","article-title":"Initial drug dissolution from amorphous solid dispersions controlled by polymer dissolution and drug-polymer interaction","volume":"33","author":"Chen","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.07.007_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-5173(01)00891-2","article-title":"The mechanisms of drug release from solid dispersions in water-soluble polymers","volume":"231","author":"Craig","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0045","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/1520-6017(200010)89:10<1325::AID-JPS10>3.0.CO;2-5","article-title":"Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers","volume":"89","author":"Khougaz","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejpb.2008.05.023","article-title":"Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine","volume":"70","author":"Konno","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejps.2018.07.007_bb0060","series-title":"Physicochemical Properties and the Discovery of Orally Active Drugs: Technical and People Issues","first-page":"13","author":"Lipinski","year":"2002"},{"key":"10.1016\/j.ejps.2018.07.007_bb0065","series-title":"Poor Aqueous Solubility - An Industry Wide Problem in ADME Screening","author":"Lipinski","year":"2002"},{"key":"10.1016\/j.ejps.2018.07.007_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2015.02.003","article-title":"Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions","volume":"71","author":"Meng","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0075","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/mp300104s","article-title":"A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability","volume":"9","author":"Miller","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0928-0987(00)00173-1","article-title":"Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25","volume":"12","author":"Mooter","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0085","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s11095-016-1913-5","article-title":"Leaching of lopinavir amorphous solid dispersions in acidic media","volume":"33","author":"Na","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.07.007_bb0090","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1208\/s12249-015-0451-5","article-title":"Development of a robust method for simultaneous quantification of polymer (HPMC) and surfactant (dodecyl \u03b2-d-maltoside) in nanosuspensions","volume":"17","author":"Patel","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2018.07.007_bb0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejps.2014.10.012","article-title":"Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging","volume":"67","author":"Pudlas","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0100","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1007\/s11095-017-2265-5","article-title":"Phase behavior of ritonavir amorphous solid dispersions during hydration and dissolution","volume":"34","author":"Purohit","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.07.007_bb0105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11095-012-0873-7","article-title":"Insights into the role of polymer-surfactant complexes in drug solubilisation\/stabilisation during drug release from solid dispersions","volume":"30","author":"Qi","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.07.007_bb0110","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.22074","article-title":"Drug-polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development","volume":"99","author":"Qian","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0115","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s11095-012-0695-7","article-title":"Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications","volume":"29","author":"Qian","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.07.007_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpba.2007.01.015","article-title":"Developing a versatile gradient elution LC\/ELSD method for analyzing cellulose derivatives in pharmaceutical formulations","volume":"44","author":"Rashan","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2018.07.007_bb0125","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/js980004q","article-title":"Polymer erosion and drug release characterization of hydroxypropyl hethylcellulose matrices","volume":"87","author":"Reynolds","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0130","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/mp900050c","article-title":"Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture","volume":"6","author":"Rumondor","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.23425","article-title":"Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process","volume":"102","author":"Shah","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0140","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jps.2600580503","article-title":"Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates","volume":"58","author":"Simonelli","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.07.007_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9673(01)93706-9","article-title":"Study of the qualitative and quantitative properties of the light-scattering detector","volume":"288","author":"Stolyhwo","year":"1984","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejps.2018.07.007_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/DDC-120027506","article-title":"Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions","volume":"30","author":"Tanno","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0155","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1021\/mp300083e","article-title":"Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements","volume":"9","author":"Ueda","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0160","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1021\/mp400278j","article-title":"Inhibitory effect of hydroxypropyl methylcellulose acetate succinate on drug recrystallization from a supersaturated solution assessed using nuclear magnetic resonance measurements","volume":"10","author":"Ueda","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2014.01.005","article-title":"The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement","volume":"464","author":"Ueda","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0170","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/cr940351u","article-title":"Polymeric systems for controlled drug release","volume":"99","author":"Uhrich","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2018.07.007_bb0175","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1007\/s11095-015-1709-z","article-title":"Phase behavior of resveratrol solid dispersions upon addition to aqueous media","volume":"32","author":"Wegiel","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.07.007_bb0180","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0731-7085(02)00394-1","article-title":"Simultaneous determination of ibuprofen and hydroxypropylmethylcellulose (HPMC) using HPLC and evaporative light scattering detection","volume":"30","author":"Whelan","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2018.07.007_bb0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpharm.2013.05.013","article-title":"Drug precipitation inhibitors in supersaturable formulations","volume":"453","author":"Xu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.07.007_bb0190","first-page":"27","article-title":"Amorphous pharmaceutical solids: preparation, characterization and stabilization","volume":"32","author":"Yu","year":"2001","journal-title":"ChemInform"},{"key":"10.1016\/j.ejps.2018.07.007_bb0195","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jp3106716","article-title":"Crystallization and dissolution behavior of naproxen\/polyethylene glycol solid dispersions","volume":"117","author":"Zhu","year":"2013","journal-title":"J. Phys. Chem. B"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718303051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718303051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T21:40:19Z","timestamp":1534801219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718303051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":39,"alternative-id":["S0928098718303051"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.07.007","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-sensitivity HPLC-ELSD method for HPMC-AS quantification and its application in elucidating the release mechanism of HPMC-AS based amorphous solid dispersions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}